TENX News and Press, Tenax Therapeutics Inc. From 02/02/23

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com It’s time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! Moving stocks this morning are study results, earni...

Patent is expected to provide additional intellectual property protection until 2040 Prevalence estimates indicate that PH-HFpEF affects over 1,500,000 patients in the U.S. There are currently no FDA approved treatments for PH-HFpEF CHAPEL HILL, N.C., Feb. 01, 2023 ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock.com Crown ElectroKinetics (NASDAQ: CRKN ) stock is taking off on Wednesday after revealing an acquisition deal with Amerigen 7 . Crown ElectroKinetics is acquiring Amerigen 7 for $645,000, ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: iQoncept / Shutterstock Tenax Therapeutics (NASDAQ: TENX ) stock is on the move Wednesday after the company announced plans for a reverse stock split . At 5:00 p.m. Eastern Time today TENX stock will unde...

Tenax Therapeutics ( NASDAQ: TENX ) is set to implement a 1-for-20 reverse stock split of its outstanding shares of common stock. Every 20 shares of company common stock will be automatically combined into one share of common stock. The split, which will become effective at 5:...

MORRISVILLE, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today that it...

Penny Stocks Under $1: Are They A Buy Or Too Risky? The definition of penny stocks includes companies trading at levels less than $5 per share. But ask any traditionalist, and they’ll tell you that there’s a different definition that involves stocks under $1. The so-called...

MORRISVILLE, N.C., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announces the pr...

Tenax Therapeutics ( NASDAQ: TENX ) on Thursday said it is evaluating strategic alternatives including a sale or a merger as it believes its current valuation does not reflect the potential value of its clinical-stage pipeline. Shares of the micro-cap specialty pharmaceuti...

MORRISVILLE, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced ...